Zimbabwe has declined a major US health deal valued at 367 million US dollars (272 million pounds) spanning five years over the United States' request for confidential data.
The decision was revealed after a internal memorandum from December was leaked, revealing that President Emmerson Mnangagwa believed the arrangement was "lopsided".
A government spokesperson later explained that the United States was seeking biological samples for research and profit while was not willing to guarantee the resulting advantages from future medical innovations.
"We are forced to start the challenging and unfortunate task of winding down our health assistance in Zimbabwe," said US ambassador to Zimbabwe Pamela Tremont in a statement.
Her embassy noted the US had furnished over $1.9bn for health programmes to Zimbabwe during the past two decades.
A physicians' group in Zimbabwe has appealed for further dialogue to secure a agreement acceptable to all parties so the nation's vital HIV programme can continue.
Wider Implications
This development comes after a comparable situation in neighbouring Kenya, where a high court suspended a similar health funding agreement following legal challenges were raised about the safety of citizens' medical information.
Since resuming the presidency last year, US President Donald Trump has slashed overseas assistance and shut down the key foreign aid agency.
The agency had managed aid for the US government, but Trump argued its spending was "inefficient" and his government was pursuing direct bilateral agreements to enhance transparency and responsibility.
As per reports, 16 nations in Africa have to date agreed to these new agreements, constituting over $18.3bn in new funding.
Details of the Rejected Agreement
The money for Zimbabwe would have funded "HIV/Aids treatment and prevention, tuberculosis, malaria, maternal and child health, and preparing for epidemics".
"It is our view this cooperation might have yielded immense benefits for Zimbabwean communities, particularly the 1.2 million presently receiving antiretroviral therapy via US-supported initiatives," Tremont added.
However, government spokesperson Nick Mangwana maintained the arrangement was "asymmetrical".
"Zimbabwe was being asked to surrender its genetic material and health information indefinitely, with no corresponding promise of access to any scientific breakthroughs – such as vaccines, diagnostics, or treatments – that might be developed from that provided information," his statement read.
"Put simply, our country would provide the raw materials for medical research with no assurance that the end products would be available to our citizens should a new disease outbreak emerge."
Sovereignty and International Frameworks
Mangwana further noted that the American exit from the global health body and its pursuit of one-on-one health agreements were undermining systems previously established through the international organization.
The spokesperson cited its Pathogen Access and Benefit Sharing scheme designed to deal with potential pandemics.
"This framework is intended to ensure that when a country contributes its samples, the benefits – including vaccines and treatments – are shared equitably, not monopolised solely by those with the funds to develop them."
These objections over the US deal "must not be interpreted as opposition to America," he added.
"We welcome continued discussions with our American counterparts on how subsequent co-operation might be designed in a way that honours the sovereignty and dignity of each country."
Health Experts Reaction
The Zimbabwe College of Public Health Physicians (ZCPHP) stated it recognised the government's concerns, but recommended that negotiations must proceed considering much of the country's HIV programmes were funded by foreign aid.
"If specific concerns arise, such as those involving data governance or agreement terms, these can frequently be addressed through technical clarification and mutually agreed protections," it commented.
This impasse emphasises the continuing debate between accepting vital foreign assistance and protecting national sovereignty in an ever more data-driven world.